275
Participants
Start Date
February 24, 2017
Primary Completion Date
August 31, 2021
Study Completion Date
August 31, 2021
ANG-3777
6 mg/mL BB3, IV, 4 days in a row, first dose must be within 4 hours after surgery, the next three doses will be approx. 24 hours after the last dose
Placebo
Normal saline
Columbia University Medical Center, New York
Suburban Hospital, Bethesda
University of Maryland Medical Center, Baltimore
University of Virginia Health System, Charlottesville
Wake Forest University School of Medicine, Winston-Salem
Duke University, Durham
Fleming Island Center for Clinical Research, Fleming Island
River City Clinical Research, Jacksonville
UF Health at Unviersity of Florida, Gainesville
Ohio State Wexner Medical Center, Columbus
Cleveland Clinic Fairview, Cleveland
TriHealth, Cincinnati
Indiana Ohio Heart, Fort Wayne
MidMichigan Medical Center Midland, Midland
Cardiac & Vascular Research Center of Northern Michigan, Petoskey
Bryan Heart, Lincoln
Baylor Jack and Jane Hamilton Heart and Vascular center- Soltero Cardiovascular Research Center, Dallas
University of Texas Southwestern Medical Center, Dallas
University of Southern California, Los Angeles
Cedars-Sinai Medical Center, Los Angeles
California Institute of Renal Reseach, San Diego
Stanford University Medical Center, Palo Alto
Yale University School of Medicine, New Haven
Faculdade de Medicina da UNESP Campus de Botucatu, Botucatu
Instituto de Cardiologia do Rio Grande do Sul / Fundação Universitária de Cardiologia (IC - FUC), Porto Alegre
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (HCFMRP), Ribeirão Preto
Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto
Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (InCor - HCFMUSP), São Paulo
St. John Regional Hospital, Saint John
London Health Sciences Center, London
Saint Michael's Hospital, Toronto
CHUM - Hôtel Dieu, Montreal
MUHC - Royal Victoria Hospital, Montreal
Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec
Israeli-Georgian Medical Research Clinic Helsicore, Tbilisi
New Hospitals LTD, Tbilisi
Bokhua Memorial Cardiovascular Center, Tbilisi
Jerarsi JSC, Tbilisi
Tbilisi Heart Center, Tbilisi
Acad. G. Chapidze Emergency Cardiology Center, Tbilisi
Lead Sponsor
Everest Clinical Research
UNKNOWN
CTI Clinical Trial and Consulting Services
OTHER
Clinical Accelerator
INDUSTRY
Angion Biomedica Corp
INDUSTRY